Study of Broader Efficacy of Atomoxetine in the Treatment of ADHD in Children/Adolescents

Clinical trial NCT00191659 · COMPLETED

Trial details

NCT number: NCT00191659
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder

Start date: 2004-06-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.